Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000905718-15-000933)

Filing Details

Accession Number:: 0000905718-15-000933
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-11-25 16:09:16
Reporting Period:: 2015-11-23

Filing Date:: 2015-11-25
Accepted Time:: 2015-11-25 16:09:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
744218	Celldex Therapeutics Inc.	CLDX	In Vitro & In Vivo Diagnostic Substances (2835)	133191702

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1255348	W Avery Catlin	C/O Celldex Therapeutics, Inc. 53 Frontage Road Hampton NJ 08827	Sr. Vp & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-11-23	25,000	$8.52	60,109	No	4	M	Direct
Common Stock	Disposition	2015-11-23	25,000	$18.00	35,109	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option	Disposition	2015-11-23	25,000	$0.00	25,000	$8.52

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2013-01-06	2019-01-06	No	4	M	Direct

Footnotes

The sale reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2015. The options exercised and sold by the Reporting Person were due to expire January 6, 2019.
As of January 6, 2013, the option is fully vested.